Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox versus glyceryl trinitrate for chronic anal fissure
ACTRN12622000432718Phase 4Not yet recruiting
- Sponsor
- Khyber Medical College
- Start
- Jun 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in chronic anal fissure (CAF) comparing Botox injection with Glyceryl trinitrate ointment (2 arms). Primary endpoint: Fissure healing. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
botulinum toxin type Anitroglycerin
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on ACTRN12622000432718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000432718.